# ANG Lifesciences India Ltd (ANG) > Exchange: NSE | Sector: Pharma | ISIN: ## Price Current Price: ₹26.88 Day Change: -2.33% 52W High: ₹39.7 52W Low: ₹17.63 Market Cap: ₹35 Cr ## Valuation P/E: 0 P/B: 0.6 EPS: ₹-9.01 Book Value: ₹44.85 Dividend Yield: 0% ## Returns 1Y Return: -5.58% ## Profitability ROE: -22.64% ROCE: 0% Debt/Equity: 0 Revenue Growth: 0% Profit Growth: 0% EBITDA Margin: 0% Operating Margin: 0% ## About ANG Lifesciences India Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place. Sector: Pharma Industry: Drug Manufacturers - Specialty & Generic Sub Industry: Unknown ## Business Model Overview: ANG Lifesciences India Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma. Source: Derived from stock data Revenue Streams: - Domestic formulations - Exports and regulated markets - Specialty or institutional sales Operating Model: - Develops, manufactures, distributes, or services healthcare products across regulated channels. - Approvals, product mix, compliance quality, and R&D productivity shape growth. Recent Context: - Announcement: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A - Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 - BSE Filing: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A ## Access Current tier: anonymous More history: Register free to see 2 more years. ## Data Freshness Quote Updated: 2026-05-17T00:08:05.800Z Price History Updated: 2026-05-19T01:02:45.722Z Latest Price History Date: 2026-05-15 Technicals Updated: 2026-05-19T01:02:45.722Z Quant Updated: 2026-05-19T01:02:45.722Z Sentiment Updated: 2026-05-19T01:02:45.722Z Financials Status: current Financials Updated: 2026-05-18T14:30:01.030Z Financials Last Attempt: 2026-05-18T14:30:01.030Z Financials Provider Tried: database Latest P&L Period: FY 2025 Latest Balance Sheet Period: FY 2025 Latest Cash Flow Period: FY 2025 ## P&L (Mar 2022) Revenue: ₹154 Cr Operating Profit: ₹14 Cr (OPM 9%) Net Profit: ₹7 Cr Tax: ₹10 Cr ## Annual P&L History Mar 2022: Rev ₹154Cr | PAT ₹7Cr | OPM 9% Mar 2023: Rev ₹354Cr | PAT ₹40Cr | OPM 19% Mar 2024: Rev ₹220Cr | PAT ₹0Cr | OPM 7% ## Balance Sheet (Mar 2023) Total Assets: ₹290 Cr Total Liabilities: ₹290 Cr Borrowings: ₹77 Cr Cash: ₹undefined Cr ## Shareholding undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% --- Source: rupiya.io/stocks/ang Disclaimer: For research and education only. Not investment advice.